微波乳腺成像在乳腺癌中的应用:Wavelia系统首次人体临床研究结果
本研究评估了低功率电磁波微波乳腺成像(MBI)原型系统在临床环境中检测和定位乳腺肿瘤及良性病变的能力,并评估其安全性和患者体验。共25例患者接受MBI,24例纳入分析(11例乳腺癌、8例未抽吸囊肿、5例活检证实的良性病变)。MBI检测并定位了13个良性病变中的12个和11例乳腺癌中的9例,包括1例影像学隐匿的浸润性小叶癌;无器械相关不良事件,92%的女性推荐该检查。结论认为MBI可检测和定位大多数乳腺病变,可能成为乳腺癌诊断的非侵入、非电离、无痛的辅助手段,但需更大规模研究验证。
要点
- MBI检测并定位了11例乳腺癌中的9例,包括1例影像学隐匿的浸润性小叶癌。
- MBI检测并定位了13个良性乳腺病变中的12个,涵盖囊肿和活检证实的良性病变。
- 无器械相关不良事件,92%的女性表示会向其他女性推荐MBI检查。
关键影像表现/征象
- MBI检测并定位了13个良性乳腺病变中的12个。
- MBI检测并定位了11例乳腺癌中的9例。
- 检测到1例影像学隐匿的浸润性小叶癌。
临床应用与阅片要点
- MBI可作为乳腺癌诊断的非侵入、非电离、无痛辅助手段,尤其对影像学隐匿的浸润性小叶癌有潜在检出价值。
局限性
- 样本量小(24例纳入分析),需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Microwave Breast Imaging (MBI) is an emerging non-ionising technology with the potential to detect breast pathology. The investigational device considered in this article is a low-power electromagnetic wave MBI prototype that demonstrated the ability to detect dielectric contrast between tumour phantoms and synthetic fibroglandular tissue in preclinical studies. Herein, we evaluate the MBI system in the clinical setting. The capacity of the MBI system to detect and localise breast tumours in addition to benign breast pathology is assessed. Secondly, the safety profile and patient experience of this device is established.
MATERIALS AND METHODS: Female patients were recruited from the symptomatic unit to 1 of 3 groups: Biopsy-proven breast cancers (Group-1), unaspirated cysts (Group-2) and biopsy-proven benign breast lesions (Group-3). Breast Density was determined by Volpara VDM (Volumetric Density Measurement) Software. MBI, radiological, pathological and histological findings were reviewed. Subjects were surveyed to assess patient experience.
RESULTS: A total of 25 patients underwent MBI. 24 of these were included in final data analysis (11 Group-1, 8 Group-2 and 5 Group-3). The MBI system detected and localised 12 of 13 benign breast lesions, and 9 out of the 11 breast cancers. This included 1 case of a radiographically occult invasive lobular cancer. No device related adverse events were recorded. 92% (n = 23) of women reported that they would recommend MBI imaging to other women.
CONCLUSION: The MBI system detected and localized the majority of breast lesions. This modality may have the potential to offer a non-invasive, non-ionizing and painless adjunct to breast cancer diagnosis. Further larger studies are required to validate the findings of this study.
引用
- Moloney BM, McAnena PF, Abd Elwahab SM, et al. Microwave Imaging in Breast Cancer - Results from the First-In-Human Clinical Investigation of the Wavelia System. Acad Radiol. 2021. PMID: 34364762. doi:10.1016/j.acra.2021.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。